OUTCOMES FOLLOWING LIVING DONOR KIDNEY TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION

被引：0
|
作者：
Kaelble, Florian [1 ]
da Silva, Luiza Pego [1 ]
Schaier, Matthias [1 ]
Zeier, Martin [1 ]
Mehrabi, Arianeb [3 ]
Suesal, Caner [2 ]
Morath, Christian [1 ]
机构：
[1] Univ Hosp Heidelberg, Nephrol, Heidelberg, Germany
[2] Univ Hosp Heidelberg, Transplantat Immunol, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Visceral & Transplantat Surg, Heidelberg, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP698
引用
收藏
页码：1582 / 1582
页数：1
相关论文
共 50 条
  • [21] Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation
    Hourmant, M
    Cesbron-Gautier, A
    Terasaki, PI
    Mizutani, K
    Moreau, A
    Meurette, A
    Dantal, J
    Giral, M
    Blancho, G
    Cantarovich, D
    Karam, G
    Follea, G
    Soulillou, JP
    Bignon, JD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09): : 2804 - 2812
  • [22] Donor-specific HLA antibodies and transplant outcomes
    Nature Reviews Nephrology, 2012, 8 (8) : 433 - 433
  • [23] Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
    Lefaucheur, Carmen
    Loupy, Alexandre
    Hill, Gary S.
    Andrade, Joao
    Nochy, Dominique
    Antoine, Corinne
    Gautreau, Chantal
    Charron, Dominique
    Glotz, Denis
    Suberbielle-Boissel, Caroline
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (08): : 1398 - 1406
  • [24] Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus with Cyclosporine After Kidney Transplantation
    Liefeldt, L.
    Brakemeier, S.
    Glander, P.
    Waiser, J.
    Lachmann, N.
    Schoenemann, C.
    Zukunft, B.
    Illigens, P.
    Schmidt, D.
    Wu, K.
    Rudolph, B.
    Neumayer, H. -H.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1192 - 1198
  • [25] Desensitization using IVIG alone for living-donor kidney transplant: impact on donor-specific antibodies
    Ulisses, Luiz Roberto de Sousa
    Paixao, Jenaine Oliveira
    Agena, Fabiana
    Souza, Patricia Soares de
    Paula, Flavio J.
    Bezerra, Gislene
    Rodrigues, Helcio
    Panajotopolous, Nicolas
    David-Neto, Elias
    de Castro, Maria Cristina Ribeiro
    JORNAL BRASILEIRO DE NEFROLOGIA, 2022, 44 (04): : 527 - 532
  • [26] Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis
    Klein, Katrin
    Suesal, Caner
    Schaefer, Sebastian M.
    Becker, Luis Eduardo
    Beimler, Joerg
    Schwenger, Vedat
    Zeier, Martin
    Schemmer, Peter
    Macher-Goeppinger, Stephan
    Scherer, Sabine
    Opelz, Gerhard
    Morath, Christian
    ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (01) : 199 - 202
  • [27] DONOR-SPECIFIC ANTIBODIES IN KIDNEY DECEASED DONOR TRANSPLANTATION.
    Ho, Eric K.
    Tang, Xiuwei
    Li Lingzhi
    Ratner, Lloyd E.
    Vlad, George
    Vasilescu, Rodica E.
    HUMAN IMMUNOLOGY, 2015, 76 : 143 - 143
  • [28] Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation
    Lefaucheur, Carmen
    Suberbielle-Boissel, Caroline
    Hill, Gary S.
    Nochy, Dominique
    Andrade, Joao
    Antoine, Corinne
    Charron, Dominique
    Glotz, Denis
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 510 - 510
  • [29] Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation
    Lefaucheur, C.
    Suberbielle-Boissel, C.
    Andrade, J.
    Charron, D.
    Glotz, D.
    TISSUE ANTIGENS, 2008, 71 (04): : 296 - 296
  • [30] Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy
    Reinsmoen, Nancy L.
    Lai, Chih-Hung
    Vo, Ashley
    Cao, Kai
    Ong, Geraldine
    Naim, Mehrnoush
    Wang, Qi
    Jordan, Stanley C.
    TRANSPLANTATION, 2008, 86 (06) : 820 - 825
12345